POINT Biopharma Global Inc. (PNT) Reports Q4 EPS of $1.53

POINT Biopharma Global Inc. (NASDAQ: PNT) reported Q4 EPS of $1.53, versus ($0.16) reported last year. Revenue for the quarter came in at $226.6 million, versus $0 reported last year.

For earnings history and earnings-related data on POINT Biopharma Global Inc. (PNT) click here.

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• Dycom Industries (DY) Tops Q2 EPS by 59c, Beats on Revenue
• Elastic NV. (ESTC) PT Raised to $80 at DA Davidson Ahead of Q1 Earnings